Interviewing one of the legendary interviewers in broadcasting history can be a nerve-wracking, intimidating experience. A few minutes into the conversation with Charlie Rose, however, I felt like I was conversing with an old friend.
We’re heading off to attend the Society for Neuroscience’s Annual Meeting, which officially starts next Saturday in Washington, DC. Some 30,000 neuroscientists and others will converge in the Walter E. Washington Convention Center – a city’s worth of brain-lovers! Just before that, we’ll be taking in the annual meeting of the International Neuroethics Society (INS), held at the AAAS Building, just down the street. Stay tuned for posts and photos from both. Here’s some of what we’re looking forward to; many of the non-science sessions this year are on aspects of science communication and outreach.
NOTE: If you’re nearby, some of these events are free and open to the public—come by and say hi!
Thursday, Nov. 9
5:30 pm to 8 pm (Eastern time) “To Tell the Truth!,” a public forum where an international group of experts will discuss how we learn to lie, why some people lie a lot, and the limits on our abilities to detect lies—even when we are lying to ourselves. Come on by if you’re in the DC area: This event, part of the INS meeting at AAAS, is free, but please register.
I first met Joe Coyle five years ago when I joined the Dana Foundation as editor of Cerebrum and inherited an advisory board of a half-dozen Dana Alliance members who were considered among the world’s top neuroscientists in their specialty areas. Since I had limited experience in covering neuroscience, Joe helped get me through my first year by providing sage advice on the latest research breakthroughs and recommending the best scientists to write on particular topics. As editor of JAMA Psychiatry for over a decade and past president of the Society for Neuroscience, his expertise in all things having to do with brain research is remarkable.
So it came as no surprise to me and our advisory board members when, this week, Joe was honored by The National Academy of Medicine (NAM) with the 2017 Rhoda and Bernard Sarnat International Prize in Mental Health. The prize recognizes achievements in basic science, clinical application, and public policy that lead to progress in the understanding, etiology, prevention, treatment, or cure of mental disorders.
Summer is officially over and we’re gearing up for a busy–and brainy–fall in New York City. There are a lot of public events coming up that we wanted to highlight.
First up, our neuroscientist friends at braiNY are headed to CAVEAT on September 29 for a neuroscience-themed happy hour. With promises to teach you “science-based party tricks from experts that will make you the coolest kid at the party,” this is surely an event not to be missed.
As we look forward to the 2017 International Neuroethics Society (INS) Annual Meeting in Washington, DC, November 9-10, we’ll be bringing you a sneak peek of what to expect through a series of interviews with some of the meetings’ speakers. Registration for the meeting is now open, and an early bird discount is in effect until September 30.
First published in the INS Newsletter:
Rémi Quirion, the first Chief Scientist of Québec, will give a plenary lecture at the 2017 Annual Meeting in Washington, D.C. His research lies in the field of neuropharmacology, specifically in relation to aging and neurological diseases such as dementia and Alzheimer’s.
How did you become interested in or involved with this type of research?
My research lab was based in a mental health hospital. There I was surrounded by many people suffering from various types of mental illnesses and neurological disease, so it familiarized me with different issues related to mental health and exposed me to the line between neuroscience and ethics, which I sought to understand more and more in the treatment of mental illnesses.